Results 281 to 290 of about 118,639 (364)

Real‐World Comparison of Vascular Access Closure Strategies in TAVI

open access: yes
Catheterization and Cardiovascular Interventions, EarlyView.
Saif Zako   +9 more
wiley   +1 more source

Recent Progress on Enzyme Immobilization: Materials, Strategies, and Applications

open access: yesFood Bioengineering, EarlyView.
Enzyme immobilization technology has undergone substantial evolution driven by advances in materials science. This review systematically examines the recent advances in enzyme immobilization since 2024, with a focused analysis of five major categories of enzyme carriers including covalent organic framework, metal‐organic frameworks, polymers, carbon ...
Shuran Wang   +7 more
wiley   +1 more source

Turmeric Polymer Fiber Mats (T-PFMs): Solution Blow Spun Turmeric/PLGA Composites as a Comprehensive Wound Care Platform. [PDF]

open access: yesACS Appl Polym Mater
Kalluraya Yogesh K   +8 more
europepmc   +1 more source

Comparative Use of Double Bipolar Forceps Versus Ultrasound Energy Device in Transoral Robotic Thyroidectomy

open access: yesHead &Neck, EarlyView.
ABSTRACT Purpose Transoral robotic thyroidectomy (TORT) offers excellent cosmetic outcomes and safe access to the central neck without a cervical incision. Traditionally, ultrasonic energy devices have been used for dissection and hemostasis, though these instruments are limited by unilateral use, bulkiness, and greater thermal spread.
Moon Young Oh   +5 more
wiley   +1 more source

Unexplained bleeding tendency and scleroderma-like skin changes: a diagnostic journey to vitamin C deficiency. [PDF]

open access: yesRes Pract Thromb Haemost
Winkler F   +7 more
europepmc   +1 more source

Risk of hemorrhagic stroke in warfarin‐treated patients following heart valve replacement: Findings from the MAGPIE study

open access: yesIbrain, EarlyView.
Among 568 mechanical heart valve replacement patients in Bangladesh, hemorrhagic stroke occurred in 4.4% with 52% mortality. Severe pulmonary hypertension increased risk 4.4‐fold, and warfarin therapy ≥104 months nearly doubled the risk, highlighting the need for long‐term risk monitoring in anticoagulated valve patients.
Dipannita Adhikary   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy